Skip to content

Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults

Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults: A Randomized Crossover Proof-of-Concept Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07695441
Acronym
Bot-Fit Health
Enrollment
22
Registered
2026-07-10
Start date
2026-03-17
Completion date
2026-04-25
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults, Postprandial Glycemic Response

Keywords

Wearable hip exoskeleton, Bot-Fit, Postprandial glucose, Walking, Energy expenditure, Healthy adults

Brief summary

This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in healthy adults. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions.

Detailed description

This study investigated whether walking with a wearable hip exoskeleton could modulate postprandial glycemic and physiological responses in healthy adults. Using a randomized crossover design, each participant completed four experimental conditions in a controlled laboratory setting: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. Postprandial glucose responses were assessed after meal ingestion during each experimental trial. Physiological responses, including heart rate, perceived exertion, and energy expenditure, were also evaluated to compare the metabolic and perceptual demands of walking with and without the wearable hip exoskeleton. The study was designed as a proof-of-concept trial to examine whether wearable hip exoskeleton-assisted walking may influence postprandial glucose regulation in healthy adults.

Interventions

BEHAVIORALWalking Without Bot-Fit

Participants performed walking without wearing the Bot-Fit wearable hip exoskeleton during the postprandial period.

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode during the postprandial period.

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode during the postprandial period.

Sponsors

CHA University
Lead SponsorOTHER
Samsung Electronics
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Each participant completed four experimental conditions in a randomized crossover design: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode.

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged 20 to 65 years. * Participants who were able to complete walking trials with and without the wearable hip exoskeleton. * Participants who provided written informed consent before participation.

Exclusion criteria

* Participants with diagnosed metabolic, cardiovascular, neurological, or musculoskeletal disorders. * Participants with conditions that could affect walking ability or safe use of the wearable hip exoskeleton. * Participants taking medications known to affect glucose metabolism. * Participants who were unable to comply with the study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Incremental Area Under the Curve for Postprandial GlucoseUp to 120 minutes after meal ingestion during each experimental trialIncremental area under the curve for postprandial glucose was calculated during the postprandial measurement period for each experimental condition.

Secondary

MeasureTime frameDescription
Peak Postprandial Glucose ConcentrationUp to 120 minutes after meal ingestion during each experimental trialThe peak glucose concentration observed during the postprandial measurement period was compared across experimental conditions.
Heart Rate ResponseFrom the start to the end of the 30-minute intervention or control period on each experimental trial dayHeart rate was assessed during each experimental condition to evaluate physiological responses to walking with and without the wearable hip exoskeleton.
Rating of Perceived ExertionImmediately after each experimental conditionRating of perceived exertion was assessed to compare subjective exercise intensity across walking conditions.

Countries

South Korea

Contacts

PRINCIPAL_INVESTIGATORSeung-Bo Park, Ph.D

CHA University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026